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2017 REPORT HIGHLIGHTS* 
 
 
             
In 2017, 45,032 index patients were identified across all HIV Partner Services programs and 
named a total of 30,386 partners. 
                                               
                                                                       
                                                                                                     
Data Source: NHM&E Partner Services data (January 1, 2017- December 31, 2017) as of September 16, 2018 
 
 
 
 
 
*This report focuses on reported percentages calculated by excluding missing data, thus possibly overestimating the true values for the indicators. 
1 An index patient is eligible for partner services if he or she is not deceased or out of jurisdiction at the time of report. 
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2017 REPORT HIGHLIGHTS* 
 
 
                                                       
Of the 7,728 partners tested with a documented HIV test result, 19% (1,456) were newly 
identified as HIV-positive. Of the total named partners, an overall yield of 5% newly 
identified HIV positivity was achieved (1,456/30,386). 
                                                           
Data Source: NHM&E Partner Services data (January 1, 2017-December 31, 2017) as of September 16, 2018 
 
*This report focuses on reported percentages calculated by excluding missing data, thus possibly overestimating the true values for the indicators. 
1 Partners named, for whom a record was created in the NHM&E client-level partner services database in EvaluationWeb®. The total includes partners determined to be 
out of jurisdiction, deceased, not notifiable due to assessed risk for potential violence on the part of the index patient or the partner, or previously diagnosed with HIV 
infection. 2 Partners that are not known to be HIV-positive, out of jurisdiction, deceased, or potentially violent. 
3 Partners who test positive for HIV infection after having no evidence of previous HIV diagnosis from cross-check with the health department surveillance system, review of 
laboratory reports, medical records, or other available data sources (e.g., partner services database, evidence of previous treatment for HIV); or patient self-report. 
4 The referring agency has confirmed that the client accessed the HIV medical care to which he or she was referred. The denominator excludes missing data as well as “pending,” 
“lost to follow-up,” “no follow-up,” and “don’t know” options. 
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Introduction 
In 2017, 38,281 people were newly diagnosed with HIV in the United States.1 Many of these new infections 
occur following exposure to HIV from people who are infected but not receiving medical care.2 Some of 
these people have not yet been diagnosed, others have been diagnosed but were never linked to HIV 
medical care, and still others were linked to HIV medical care but were subsequently lost to medical follow-
up. The most critical challenge for HIV prevention is to identify people with HIV infection who are not in care, 
help them access care so they can receive treatment with antiretroviral therapy (ART), and help them remain 
in care.  Achieving viral suppression while in care is key to improving health outcomes; once sustained viral 
suppression is achieved, there is effectively no risk of sexually transmitting HIV. 
 
Partner services is a key strategy for identifying people with HIV infection—those with undiagnosed infection 
and those with previously diagnosed infection who are not receiving HIV medical care—and helping them 
access care and treatment. All persons with newly diagnosed HIV infection should receive partner services to 
help them identify sex and needle-sharing partners who may also be infected or may be at very high risk for 
becoming infected.3 These partners can then be notified of their potential exposure and offered HIV testing. 
Those who test positive for HIV can then be linked to HIV medical care and other services. 
 
Partner services can also help persons living with HIV and their partners address other needs, such as 
reducing behavioral risk for transmitting or acquiring HIV; accessing treatment for mental health issues and 
substance abuse; and obtaining social services to address unmet housing, transportation, employment, and 
other needs. 
 
This report summarizes the 2017 client-level partner services data submitted by CDC-funded jurisdictions in 
the United States and dependent areas (i.e., Puerto Rico and U.S. Virgin Islands). 
 
 
1 Centers for Disease Control and Prevention. HIV Surveillance Report, 2017; vol. 29. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published 
November 2018. Accessed February 1, 2019. 
2 Centers for Disease Control and Prevention. Vital Signs: HIV Transmission along the Continuum of Care — United States, 2016. MMWR 2019;68:267–272. 
3 Centers for Disease Control and Prevention. CDC Recommendations for Partner Services Programs for HIV Infection, Syphilis, Gonorrhea, and Chlamydial Infection. 
MMWR 2008; 57(No. RR-9):[1-83]. 
 
7 
 
Methods 
Health departments collect standardized client-level National HIV Prevention Program Monitoring and 
Evaluation (NHM&E) partner services data that are submitted to CDC twice yearly for monitoring at the 
national level. Data are reported through EvaluationWeb®, a secure, web-based software tool made 
available to recipients by CDC. The data undergo a quality assurance process and are then used to calculate 
program indicators at the national and jurisdictional levels to assess progress at each step of the partner 
services process. Indicators are stratified by age, gender, race/ethnicity, subpopulation4, and geographic 
region5 as defined by the U.S. Census Bureau. Behavioral risk data used to define the subpopulation is only 
required and reported for individuals diagnosed as HIV-positive. 
 
Analyses for all tables in this report are based on NHM&E client-level partner services data except for 
Table 1, which also includes aggregate-level partner services data reported to CDC as part of the quality 
assurance process. 
 
This report includes all partner services cases opened during the period of January 1 – December 31, 2017. 
The partner services program indicators included in this report are as follows: 
 
1. Interview of index patients (partner elicitation) 
• Percentage of eligible and located index patients who were interviewed for partner 
services 
2. Partner notification 
• Percentage of notifiable partners who were notified of their potential exposure to HIV 
infection 
3. Partner testing 
• Percentage of notified partners who were tested for HIV  infection 
• Percentage of tested partners who had newly diagnosed HIV infection 
4. Linkage to HIV medical care 
• Percentage of partners with newly diagnosed HIV infection who were linked to HIV 
medical care 
 
Indicators were calculated and reported for those records with complete data. This report focuses on 
reported6 percentages, calculated by excluding missing data, thus possibly overestimating the true values for 
the indicators. 
 
4 Subpopulations are categorized as follows: men who have sex with men and report injection drug use, men who have sex with men, 
transgender persons who report injection drug use, transgender persons, persons who inject drugs, heterosexual males, and 
heterosexual females. 
5 U.S. geographic regions include the following Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, 
Pennsylvania, Rhode Island and Vermont; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, 
Ohio, South Dakota and Wisconsin; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, 
Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia and West Virginia; West: Alaska, Arizona, 
California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington and Wyoming. U.S. Dependent Areas: 
Puerto Rico and the U.S. Virgin Islands 
6 Reported percentages exclude missing values. In addition, linkage to HIV medical care also excludes “pending,” “lost to follow-up,” “no 
follow-up,” and “don’t know” options. 
 Findings 
This report summarizes the 2017 client-level partner services data from 59 of the 61 CDC-funded 
jurisdictions in the United States and dependent areas (i.e., Puerto Rico and U.S. Virgin Islands). Data from 
two jurisdictions (Chicago and Minnesota) are not included in this report because their data were not 
available. 
 
INDEX PATIENTS 
Who Was Eligible for Partner Services? 
Almost all (99%) index patients identified by partner service programs were eligible for HIV partner 
services (Table 2). 
 
 Age: The highest percentage of eligible index patients were in the age group 20-29 years (31%) 
followed by 30-39 (27%). Only 3% of index patients were 19 years of age or younger (Table 3). 
 
 Gender: The majority of index patients were male (83%), with females and transgender persons 
accounting for 15% and 1%, respectively (Table 3). 
 
 Race/Ethnicity: A high percentage of index patients were black/African American (42%), followed 
by white (29%), and Hispanic/Latino (21%) (Table 3). 
 
 U.S. Geographic Region: More than half (52%) of index patients lived in the South (Table 3). 
 
 Subpopulation: Gay, bisexual, and other men who have sex with men (collectively referred to as 
MSM) accounted for 42% of index patients in 2017. However, behavioral risk information for a high 
proportion of index patients was missing, not asked, or unknown (33%) (Table 3). 
 
How Effective Are Partner Services Programs in Locating and Interviewing Index Patients with 
HIV Infection? 
Indicator: Percentage of eligible and located index patients who were interviewed for partner services 
 
A total of 39,378 (89%) eligible index patients were located. Of those 38,667 with a reported partner services 
enrollment status, 32,857 (85%) were interviewed to elicit partner names (Table 2). 
 
 Age: Eligible index patients aged 13-19 were most often located and interviewed (94% and 91%, 
respectively); followed closely by index patients aged 20-29 (91% and 88%, respectively) (Table 3). 
 
 Gender: Transgender persons had the lowest percentage located (86%); females and males 
were located at the same percentage (89%). A higher percentage of females (89%) were 
interviewed than males (84%) and transgender persons (82%) (Table 3). 
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  Race/Ethnicity: Hispanic/Latino and Asian index patients were located most often (92%). 
Although black/African American and white index patients were located at the same 
percentage (89%), whites had a lower percentage for partner services interviews (79%) 
(Table 3). 
 
 U.S. Geographic Region: 90% of index patients residing in the South were located for partner 
services, with the lowest percentage reported in the Midwest (83%). Over 90% of index patients 
were interviewed for partner services in U.S. dependent areas, the South, and the Northeast. Index 
patients in the West were interviewed at the lowest percentage (67%) (Table 3). 
 
 Subpopulation: Where behavioral risk was reported, subpopulation groups were located at similar 
percentages (95-98%) except for transgender persons (86%). Heterosexual women and men were 
interviewed most often (96% and 94%, respectively) and transgender and transgender persons who 
inject drugs (transgender/PWID) least often (82%) (Table 3). 
 
PARTNERS 
A total of 30,386 sex and/or needle-sharing partners were named by index patients during the 
interview process. Four performance indicators were calculated to answer key partner services program 
evaluation questions. 
 
How Effective Are Partner Services Programs in Notifying Partners of Their Potential 
HIV Exposure? 
Indicator: Percentage of notifiable partners who were notified 
 
Of the 30,386 partners that were named, 28,442 (94%) were initiated for partner services. Of the partners who 
were initiated for partner services 4,486 (16%) were excluded because they were either previously known to 
be HIV-positive, out of jurisdiction, deceased, or potentially violent. Another 1,041 records (4%) contained 
missing data on notifiablity. The remaining 22,915 (84%) were considered notifiable. Of the 22,351 notifiable 
partners with a notification method reported, a total of, 21,606 (97%) were notified of their potential HIV 
exposure (Table 4). 
 
 Age: The highest percentage of partners initiated for partner services were in the age groups 20- 
29 and 30-39 (33% and 25%, respectively). Notification of partners was more than 96% for all age 
groups except those younger than age 13 (74%) and those 13-19 (94%) (Table 5). 
 
 Gender: Of the partners initiated for partner services, 82% were male and 16% were female. 
Transgender persons accounted for less than 1% of initiated partners. The percentage of 
male, female, and transgender partners notified was at or above 96% (Table 5). 
 
 Race/Ethnicity: The majority of partners initiated for partner services were either black/African 
American (40%) or white (30%); 19% were Hispanic/Latino (Table 5). There was at least 95% 
notification of partners for all racial/ethnic groups. 
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 U.S. Geographic Region: The majority of partners initiated for partner services lived in the South 
(59%). The Midwest had the lowest percentage of partners notified (78%) (Table 5). Notification of 
partners in the other regions was 91% or higher. 
 
 Subpopulation: Overall, 14% of all named partners initiated for partner services were MSM. All 
subpopulations were notified at or above 96% (Table 5). Behavioral risk data were only required to 
be reported for partners newly diagnosed as HIV-positive; about 75% of partners were missing this 
data and could not be categorized. 
 
How Effective Are Partner Services Programs in Testing Notified Partners and Identifying HIV 
Infections? 
 
Indicator 1: Percentage of notified partners who were tested 
Indicator 2: Percentage of tested partners who were newly diagnosed with HIV infection 
 
Of the 10,106 notified partners with HIV test information (11,500 records were excluded due to missing data), 
84% (8,531) were tested for HIV (Table 4). Of the 7,728 partners tested with a documented HIV test result 
(803 records were excluded for missing data), 19% (1,456) were newly identified as HIV-positive. (Table 6). 
Even including all named partners into the denominator, partner services programs in CDC-funded health 
departments show a 5% yield of HIV-positive persons (1,456/30,386). 
 
 Age: Notified partners less than 13 years of age (93%) and those aged 13 to 19 (89%) had the 
highest percentage HIV testing. Partners 50+ had the highest percentage of being identified as 
HIV-positive (27%) (Table 7). 
 
 Gender: Although notified female partners were tested for HIV (90%) more often than transgender 
partners (87%) and male partners (83%) (Table 5), they were least likely to test HIV-positive (14%) 
compared with transgender (18%) and male (20%) partners (Table 7). 
 
 Race/Ethnicity: Although notified black/African American partners were tested for HIV (84%) at a 
lower percentage than Hispanic/Latino (88%) and white partners (86%) (Table 5), they were more 
frequently newly identified as HIV-positive (22%) compared with Hispanic/Latino (17%) and white 
(16%) partners (Table 7). 
 
 U.S. Geographic Region: U.S. Dependent Areas had the highest percentage of notified partners 
tested for HIV (97%) and the Northeast had the lowest (76%) (Table 5). The highest percentage of 
partners newly identified as HIV-positive was in the U.S. dependent areas (25%), followed by the 
Midwest (21%) and the South (20%) (Table 7). 
 
 Subpopulation: Behavioral risk data were only required to be reported for partners diagnosed as 
HIV-positive; about 75% of partners were missing this data and could not be categorized. All 
notified partners with identified risks had testing percentages at or above 87% (Table 5). The 
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highest percentages of newly diagnosed HIV-positive partners were among persons who inject 
drugs (PWID) (49%), MSM (37%), and MSM/PWID (33%) (Table 7). 
 
How Effective Are Partner Services Programs in Linking HIV-Positive Partners to HIV Medical 
Care Services? 
 
Indicator: Percentage of partners with newly diagnosed HIV infection who were linked to HIV medical care 
 
Partners who test positive for HIV should be linked as soon as possible to HIV medical care. In 2017, a total 
of 1,456 partners from all partner services programs were newly identified as HIV-positive. Of the 585 newly 
identified HIV-positive partners with follow-up information to verify that services were accessed (871 
records or 60% were excluded for missing data or a non-confirmed care status), 563 (96%) were linked to 
HIV medical care (Table 6). 
 
    Age: Newly identified HIV-positive partners in every age group had a linkage to HIV medical care 
percentage of 94% or higher (Table 7). 
 
 Gender: Female and male newly identified HIV-positive partners had similar linkage to HIV medical 
care percentages at 98% and 96%, respectively. All three newly identified HIV-positive transgender 
partners were linked (Table 7). 
 
 Race/Ethnicity: All (100%) newly identified HIV-positive Hispanic/Latino partners were linked to HIV 
 medical care followed by 96% of black/African American partners and 95% of white partners (Table 7). 
 
 U.S. Geographic Region: All (41) newly identified HIV-positive partners who lived in U.S. 
dependent areas were linked to HIV medical care. Percentages were more than 98% in the 
other regions except for the Midwest (90%) (Table 7). 
 Subpopulation: Among newly identified HIV-positive partners who could be categorized as one of the 
listed subpopulations, those categorized as PWID had the lowest linkage (79%) with all other linkage 
percentages higher than 88% (Table 7). 
 
Limitations 
 
While partner services data reporting and quality are continuously improving, the interpretation of findings 
contained in this report was informed by the level of missing data on key variables and the factors that 
contributed to missing data. 
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In the 2017 partner services data, several key variables used to calculate program 
performance indicators had missing data ranging between 2% and 60% of the total 
records. 
 
• Enrollment Status for Index Patients 2% 
• Partner Notifiability 4% 
• Partner Notification 2% 
• HIV Test Performed for Partners 53% 
• Test Results for Partners 9% 
• Linkage to HIV Medical Care 60% 
 
This report focuses on “reported” percentages calculated by excluding missing data, thus probably 
overestimating the true values for the indicators, especially for those indicators with relatively high 
missing data (i.e., HIV Test Performed for Partners, Test Results for Partners, and Linkage to HIV 
Medical Care). 
 
In addition, other important variables that are required to describe the indicators by demographic and 
other population groups (particularly behavioral risk) had a significant amount of missing data. While 
results for partner HIV testing, identification of previously undiagnosed HIV infections, and linkage to care 
for newly diagnosed HIV-positive persons indicate success, interpretations are limited by incompleteness 
of data. There is a need to further strengthen data systems to improve data completeness and our 
assessment of partner services program nationally. 
 
There are at least two factors that contributed to missing data. The first is the varied data collection 
systems used by recipients. Although the NHM&E required variables are standardized, health departments 
use different systems for collecting and reporting partner services data. The majority of recipients use their 
own locally developed, adapted systems or utilize commercially available systems (e.g., PRISM, Maven, 
PartnerServicesWeb®), while 22% used some version of STD*MIS, a recently retired CDC data collection 
tool that did not capture 14 of the key variables needed to calculate partner services program 
performance indicators. HIV testing and linkage to HIV medical care variables for newly identified HIV-
positive partners were also missing in some systems. 
 
Secondly, tracking partners’ past and current HIV test results and their linkage to care is a complex, time- 
and labor-intensive activity. At a minimum, it requires data sharing between various providers and data 
systems that are continuously updated. While many health departments verbally report linking 100% of 
their newly identified partners to HIV medical care during the semi-annual quality assurance process, their 
partner services data submitted to CDC do not reflect this for a variety of reasons. For example, missing 
data on linkage to HIV medical care may be due to program infrastructure limitations, making it difficult to 
confirm if a person has attended their first HIV medical appointment.  
 
CDC has recently developed a more comprehensive data collection tool, the National Electronic Disease 
Surveillance (NEDSS) Base System or NBS, which is designed to connect state and local levels of public 
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health to laboratories and health care providers. Several health departments have already implemented 
NBS and the enhanced data-sharing relationship should be helpful in increasing reporting and reducing 
the amount of missing information. 
 
 
Summary 
The activities involved in the partner services process are very important for identifying and linking persons 
diagnosed with HIV infections. Analysis of the 2017 data reveals that partner services programs have 
successfully interviewed index patients, elicited partner information, and notified partners of potential 
exposure to HIV. The minimum positivity rate of 5% (1,456 newly identified HIV-positive partners/30,386 total 
named partners) is supporting evidence that partner services is a high-yield strategy. However, this report 
also suggests that more emphasis be placed on getting HIV-exposed partners tested. Although most 
notifiable partners were notified of their potential HIV exposure and the notification rates among the 59 state 
and local health departments are very high, not all partners were tested for HIV. There may be partners who 
are not aware they are HIV-positive and will not be linked to HIV medical care and other services. Additional 
strategies or approaches should be used to get potentially exposed partners to confirm their HIV status. 
 
 
Terms 
Eligible- An index patient is eligible for partner services if he or she is not deceased or out of jurisdiction at 
the time of report. 
Initiated- Partners named for whom a record was created in the National HIV Prevention Program 
Monitoring and Evaluation (NHM&E) client-level partner services database in EvaluationWeb®.  
Linked to Care-The referring agency has confirmed that the client accessed the HIV medical care to which he 
or she was referred. 
National HIV Prevention Program Monitoring and Evaluation (NHM&E)- Variables used for standardized 
data collection and reporting for national and local HIV prevention monitoring and evaluation. 
Notifiable- Partners that are not known to be HIV-positive, out of jurisdiction, deceased, or potentially 
violent. 
Newly-Identified- Partners who test positive for HIV infection after having no evidence of previous HIV 
diagnosis from cross-check with the health department surveillance system, review of laboratory reports, 
medical records, or other available data source or patient self-report. 
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TABLE 1. Overview of Key Partner Services Indicators, 59 Health Departments, 2017 
 
Jurisdictions 
Index Patients  Partners  
Number of Index Patients Index Patients Interviewed Number of Partners 
Partners Tested for 
HIV 
Newly Identified HIV-
Positive Partners 
Newly Identified Partners 
Linked to Care 
Alabama 926 373 689 213 36 29 
Alaska 71 63 84 62 2 2 
Arizona 1,558 1,355 1,171 424 29 11 
Arkansas 335 302 311 155 6 3 
California (excludes LA and SF) 2,858 226 226 55 3 2 
Los Angeles 1,702 1,288 317 64 12 3 
San Francisco 264 171 383 106 7 4 
Colorado 410 362 392 232 42 40 
Connecticut 164 144 56 31 2 0 
Delaware 143 95 31 2 0 0 
District of Columbia 525 85 50 6 4 0 
Florida 7,967 6,789 3,788 1,665 57 38 
Georgia (excludes Atlanta) 305 255 136 66 13 3 
Atlanta 228 152 66 26 6 0 
Hawaii 85 58 48 11 0 0 
Idaho 89 14 68 0 0 0 
Illinois (excludes Chicago) 1,049 340 110 11 1 0 
Indiana 85 85 80 80 42 29 
Iowa 111 82 199 89 9 5 
Kansas 106 92 511 31 31 26 
Kentucky 290 250 497 22 0 0 
Louisiana 1,152 746 731 239 27 14 
Maine 43 5 16 0 0 0 
Maryland (excludes Baltimore) 1,650 1,324 533 228 7 2 
Baltimore 522 441 216 85 2 1 
Massachusetts 412 184 114 8 0 0 
Michigan 1,174 755 535 78 8 3 
Mississippi 811 753 734 388 17 9 
Missouri 474 423 372 120 9 6 
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Jurisdictions 
Index Patients Partners 
Number of Index 
Patients 
Index Patients 
Interviewed Number of Partners Partners Tested for HIV 
Newly Identified HIV-
Positive Partners 
Newly Identified Partners  
Linked to Care 
Montana 35 13 63 1 1 0 
Nebraska 62 53 47 17 3 0 
Nevada 1,215 1,156 855 256 21 16 
New Hampshire 30 26 30 1 0 0 
New Jersey 307 163 206 45 8 7 
New Mexico 168 141 106 59 12 8 
New York (excludes NYC) 652 488 572 217 25 8 
New York City 2,939 2,581 1,341 168 34 32 
North Carolina 2,019 1,876 1,869 776 435 47 
North Dakota 39 39 41 21 1 0 
Ohio 969 804 883 387 67 59 
Oklahoma 244 238 292 0 0 0 
Oregon 237 145 185 69 15 0 
Pennsylvania (excludes Philadelphia) 411 379 189 39 19 16 
Philadelphia 1,143 795 845 251 14 10 
Rhode Island 85 80 83 47 5 4 
South Carolina 548 524 332 269 171 73 
South Dakota 49 49 10 10 5 3 
Tennessee 1,052 927 555 311 69 0 
Texas (includes Houston) 4,060 3,141 5,095 382 2 0 
Utah 213 128 87 87 87 0 
Vermont 2 1 2 0 0 0 
Virginia 643 537 747 85 0 0 
Washington 1,396 691 629 189 26 1 
West Virginia 53 47 154 49 0 0 
Wisconsin 589 278 265 73 11 8 
Wyoming 16 16 8 8 0 0 
Puerto Rico 339 328 483 217 53 41 
U.S. Virgin Islands 8 1 4 0 0 0 
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TABLE 2. Index Patients Offered Partner Services (PS), 59 Health Departments, 2017 
Jurisdictions 
 
Number of Index 
Patients 
 
Number of Index Patients Eligible 
for PS Number of Index Patients Located Number of Index Patients Interviewed 
 
N 
 
% 
 
N 
Reporteda 
Denominator 
Reportedb 
% 
 
N 
Reporteda 
Denominator 
Reportedb 
% 
Alabama 926 923 99.7 523 923 56.7 373 373 100.0 
Alaska 71 71 100.0 69 71 97.2 63 69 91.3 
Arizona 1,558 1,557 99.9 1,420 1,555 91.3 1,355 1,420 95.4 
Arkansas 335 335 100.0 324 335 96.7 302 324 93.2 
California (excludes LA and SF) 2,858 2,858 100.0 2,858 2,858 100.0 226 2,858 7.9 
Los Angeles 1,702 1,698 99.8 1,312 1,698 77.3 1,288 1,312 98.2 
San Francisco 264 261 98.9 197 261 75.5 171 197 86.8 
Colorado 410 408 99.5 408 408 100.0 362 408 88.7 
Connecticut 164 163 99.4 154 163 94.5 144 150 96.0 
Delaware 143 134 93.7 107 129 82.9 95 106 89.6 
District of Columbia 525 497 94.7 111 357 31.1 85 111 76.6 
Florida 7,967 7,967 100.0 7,274 7,967 91.3 6,789 7,274 93.3 
Georgia (excludes Atlanta) 305 304 99.7 255 304 83.9 255 255 100.0 
Atlanta 228 228 100.0 152 228 66.7 152 152 100.0 
Hawaii 85 80 94.1 79 80 98.8 58 78 74.4 
Idaho 89 89 100.0 56 89 62.9 14 14 100.0 
Illinois (excludes Chicago) 1,049 887 84.6 540 887 60.9 340 485 70.1 
Indiana 85 85 100.0 85 85 100.0 85 85 100.0 
Iowa 111 110 99.1 107 109 98.2 82 107 76.6 
Kansas 106 106 100.0 105 106 99.1 92 105 87.6 
Kentucky 290 290 100.0 290 290 100.0 250 290 86.2 
Louisiana 1,152 1,021 88.6 849 996 85.2 746 849 87.9 
Maine 43 43 100.0 15 43 34.9 5 5 100.0 
Maryland (excludes Baltimore) 1,650 1,650 100.0 1,401 1,650 84.9 1,324 1,401 94.5 
Baltimore 522 522 100.0 460 522 88.1 441 460 95.9 
Massachusetts 412 392 95.1 288 392 73.5 184 288 63.9 
Michigan 1,174 1,168 99.5 1,003 1,100 91.2 755 952 79.3 
Mississippi 811 811 100.0 765 811 94.3 753 765 98.4 
Missouri 474 471 99.4 450 471 95.5 423 450 94.0 
Montana 35 35 100.0 28 35 80.0 13 13 100.0 
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Jurisdictions 
Number of Index 
Patients 
Number of Index Patients Eligible 
for PS Number of Index Patients Located Number of Index Patients Interviewed 
 
N 
 
% 
 
N 
Reporteda 
Denominator 
Reportedb 
% 
 
N 
Reporteda 
Denominator 
Reportedb 
% 
Nebraska 62 61 98.4 60 61 98.4 53 55 96.4 
Nevada 1,215 1,214 99.9 1,213 1,214 99.9 1,156 1,213 95.3 
New Hampshire 30 30 100.0 26 30 86.7 26 26 100.0 
New Jersey 307 298 97.1 237 298 79.5 163 233 70.0 
New Mexico 168 168 100.0 141 168 83.9 141 141 100.0 
New York (excludes NYC) 652 640 98.2 527 638 82.6 488 527 92.6 
New York City 2,939 2,873 97.8 2,678 2,873 93.2 2,581 2,678 96.4 
North Carolina 2,019 2,019 100.0 1,876 2,019 92.9 1,876 1,876 100.0 
North Dakota 39 39 100.0 39 39 100.0 39 39 100.0 
Ohio 969 969 100.0 960 960 100.0 804 947 84.9 
Oklahoma 244 244 100.0 238 238 100.0 238 238 100.0 
Oregon 237 233 98.3 145 233 62.2 145 145 100.0 
Pennsylvania (excludes Philadelphia) 411 411 100.0 379 410 92.4 379 379 100.0 
Philadelphia 1,143 1,136 99.4 980 1,136 86.3 795 980 81.1 
Rhode Island 85 85 100.0 81 81 100.0 80 81 98.8 
South Carolina 548 548 100.0 548 548 100.0 524 548 95.6 
South Dakota 49 49 100.0 49 49 100.0 49 49 100.0 
Tennessee 1,052 1,052 100.0 938 1,052 89.2 927 938 98.8 
Texas (includes Houston) 4,060 4,060 100.0 4,060 4,060 100.0 3,141 4,060 77.4 
Utah 213 213 100.0 156 213 73.2 128 156 82.1 
Vermont 2 2 100.0 1 1 100.0 1 1 100.0 
Virginia 643 638 99.2 594 635 93.5 537 594 90.4 
Washington 1,396 1,379 98.8 1,050 1,367 76.8 691 699 98.9 
West Virginia 53 53 100.0 53 53 100.0 47 50 94.0 
Wisconsin 589 589 100.0 309 586 52.7 278 309 90.0 
Wyoming 16 16 100.0 16 16 100.0 16 16 100.0 
Puerto Rico 339 337 99.4 337 337 100.0 328 331 99.1 
U.S. Virgin Islands 8 7 87.5 2 6 33.3 1 2 50.0 
TOTAL 45,032 44,527 98.9 39,378 44,244 89.0 32,857 38,667 85.0 
aReported denominator excludes missing data. 
bReported percentage excludes missing data. 
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Table 3. Demographic and Risk Behavior Characteristics of Index Patients Offered Partner Services (PS), 59 Health Departments, 2017 
 
Demographic and 
 Risk Characteristics 
Index Patients Eligible for PS Index Patients Located Index Patients Interviewed for PS 
 
N 
Column 
% 
 
N 
Reporteda 
Denominator 
Reportedb 
% 
 
N 
Reporteda 
Denominator 
Reportedb 
% 
AGE         
<13 74 0.2 47 73 64.4 10 15 66.7 
13-19 1,048 2.4 974 1,041 93.6 879 969 90.7 
20-29 13,932 31.3 12,586 13,852 90.9 10,849 12,400 87.5 
30-39 12,198 27.4 10,770 12,120 88.9 8,915 10,581 84.3 
40-49 7,625 17.1 6,675 7,573 88.1 5,385 6,520 82.6 
50+ 9,357 21.0 8,177 9,304 87.9 6,679 8,033 83.1 
Missing/Invalid 293 0.7 149 281 53.0 140 149 94.0 
GENDER         
Male 36,865 82.8 32,666 36,634 89.2 27,013 32,100 84.2 
Female 6,876 15.4 6,085 6,841 88.9 5,320 5,949 89.4 
Transgender 549 1.2 470 545 86.2 379 462 82.0 
Other 1 0.0 0 1 0.0 N/A N/A N/A 
Declined/Not Asked 220 0.5 147 212 69.3 137 146 93.8 
Missing/Invalid 16 0.0 10 11 90.9 8 10 80.0 
RACE/ETHNICITY         
White 12,756 28.6 11,339 12,704 89.3 8,783 11,069 79.3 
Black or African American 18,621 41.8 16,419 18,472 88.9 14,463 16,127 89.7 
Hispanic or Latino 9,405 21.1 8,599 9,393 91.5 7,471 8,523 87.7 
Asian 857 1.9 787 854 92.2 560 766 73.1 
American Indian or Alaska Native 238 0.5 211 237 89.0 184 207 88.9 
Native Hawaiian or Pacific Islander 77 0.2 68 76 89.5 56 67 83.6 
Multi-race 345 0.8 311 343 90.7 256 310 82.6 
Declined 20 0.0 20 20 100.0 7 20 35.0 
Don't Know 1,817 4.1 1,322 1,760 75.1 854 1,306 65.4 
Missing/Invalid 391 0.9 302 385 78.4 223 272 82.0 
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Demographic and  
Risk Characteristics 
Index Patients Eligible for PS Index Patients Located Index Patients Interviewed for PS 
 
N 
Column 
% 
 
N 
Reporteda 
Denominator 
Reportedb 
% 
 
N 
Reporteda 
Denominator 
Reportedb 
% 
REGION         
Northeast 6,073 13.6 5,366 6,065 88.5 4,846 5,348 90.6 
Midwest 4,534 10.2 3,707 4,453 83.2 3,000 3,583 83.7 
South 23,296 52.3 20,818 23,117 90.1 18,855 20,664 91.2 
West 10,280 23.1 9,148 10,266 89.1 5,827 8,739 66.7 
U.S. Dependent Areas 344 0.8 339 343 98.8 329 333 98.8 
SUBPOPULATION         
MSM/PWID 906 2.0 876 906 96.7 748 868 86.2 
MSM 18,575 41.7 18,064 18,518 97.5 15,814 18,011 87.8 
Transgender/PWID 29 0.1 28 29 96.6 23 28 82.1 
Transgender 520 1.2 442 516 85.7 356 434 82.0 
PWID 742 1.7 702 742 94.6 621 692 89.7 
Heterosexual Men 3,459 7.8 3,385 3,455 98.0 3,154 3,366 93.7 
Heterosexual Women 3,458 7.8 3,366 3,453 97.5 3,210 3,349 95.8 
No Risk 2,281 5.1 2,103 2,281 92.2 1,676 2,092 80.1 
Missing/Invalid 14,557 32.7 10,412 14,344 72.6 7,255 9,827 73.8 
TOTAL 44,527 100.0 39,378 44,244 89.0 32,857 38,667 85.0 
a
Reported denominator excludes missing data. 
 bReported percentage excludes missing data. 
  cMSM- Men who have sex with men 
  dPWID- People who inject drugs
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Table 4. Partners Elicited by and Tested Through Partner Services (PS), 59 Health Departments, 2017 
 
Jurisdictions 
 
Named Partner 
Initiated for PS Named Partners Who Were Notifiable Notified Partners Notified Partners Tested 
N N Reported, Denominator 
Reported,      
% N 
Reported, 
Denominator 
Reported,      
% N 
Reported, 
Denominator 
Reported, 
% 
Alabama  689 213 317 67.2 213 213 100.0 213 213 100.0 
Alaska  84 83 84 98.8 83 83 100.0 62 62 100.0 
Arizona  1,171 1,054 1,171 90.0 1,053 1,054 99.9 424 429 98.8 
Arkansas  311 282 311 90.7 281 282 99.6 155 168 92.3 
California (excludes LA SF)  226 182 226 80.5 177 182 97.3 55 70 78.6 
Los Angeles  317 136 317 42.9 127 127 100.0 64 127 50.4 
San Francisco  383 346 383 90.3 298 316 94.3 106 297 35.7 
  Colorado  392 274 392 69.9 263 274 96.0 232 263 88.2 
Connecticut  56 56 56 100.0 50 50 100.0 31 31 100.0 
Delaware  31 24 31 77.4 22 23 95.7 2 2 100.0 
District of Columbia  50 20 42 47.6 16 16 100.0 6 13 46.2 
Florida  3,788 3,574 3,788 94.4 3,572 3,574 99.9 1,665 1,808 92.1 
Georgia (excludes Atlanta) 136 132 136 97.1 130 130 100.0 66 130 50.8 
Atlanta  66 34 66 51.5 32 32 100.0 26 32 81.3 
Hawaii  48 32 46 69.6 32 32 100.0 11 11 100.0 
Idaho  68 0 1 0.0 N/A N/A N/A N/A N/A N/A 
Illinois (excludes Chicago)  110 77 110 70.0 77 77 100.0 11 77 14.3 
Indiana  80 80 80 100.0 80 80 100.0 80 80 100.0 
Iowa  199 197 198 99.5 197 197 100.0 89 159 56.0 
Kansas  511 511 511 100.0 31 511 6.1 31 31 100.0 
Kentucky  497 497 497 100.0 497 497 100.0 22 22 100.0 
Louisiana  731 535 731 73.2 535 535 100.0 239 535 44.7 
Maine  16 0 1 0.0 N/A N/A N/A N/A N/A N/A 
Maryland (excludes Baltimore) 533 533 533 100.0 532 533 99.8 228 249 91.6 
Baltimore 216 216 216 100.0 216 216 100.0 85 86 98.8 
Massachusetts 114 29 62 46.8 17 18 94.4 8 9 88.9 
Michigan 535 485 534 90.8 373 378 98.7 78 78 100.0 
Mississippi 734 725 734 98.8 725 725 100.0 388 394 98.5 
Missouri 372 224 367 61.0 189 190 99.5 120 163 73.6 
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Jurisdictions 
 
Named Partner 
Initiated for PS Named Partners Who Were Notifiable Notified Partners Notified Partners Tested 
N N Reported, Denominator 
Reported,         
% N 
Reported, 
Denominator 
Reported,       
% N 
Reported, 
Denominator 
Reported,      
% 
Montana 63 1 10 10.0 1 1 100.0 1 1 100.0 
Nebraska 47 45 47 95.7 45 45 100.0 17 17 100.0 
Nevada 855 283 855 33.1 278 282 98.6 256 256 100.0 
New Hampshire 30 18 30 60.0 17 18 94.4 1 1 100.0 
New Jersey 206 98 206 47.6 82 98 83.7 45 51 88.2 
New Mexico 106 106 106 100.0 105 106 99.1 59 59 100.0 
New York (excludes NYC) 572 291 495 58.8 289 289 100.0 217 243 89.3 
New York City 1,341 940 1,341 70.1 925 934 99.0 168 322 52.2 
North Carolina 1,869 1,517 1,869 81.2 1,440 1,440 100.0 776 776 100.0 
North Dakota 41 24 41 58.5 22 22 100.0 21 21 100.0 
Ohio 883 594 875 67.9 487 487 100.0 387 424 91.3 
Oklahoma 292 131 284 46.1 131 131 100.0 0 0 N/A 
Oregon 185 80 185 43.2 70 70 100.0 69 69 100.0 
Pennsylvania (excludes Philadelphia) 189 189 189 100.0 45 189 23.8 39 40 97.5 
Philadelphia 845 321 845 38.0 321 321 100.0 251 321 78.2 
Rhode Island 83 54 83 65.1 54 54 100.0 47 47 100.0 
South Carolina 332 295 318 92.8 285 288 99.0 269 285 94.4 
South Dakota 10 10 10 100.0 10 10 100.0 10 10 100.0 
Tennessee 555 555 555 100.0 523 555 94.2 311 523 59.5 
Texas (includes Houston) 5,095 5,094 5,094 100.0 5,094 5,094 100.0 382 387 98.7 
Utah 87 87 87 100.0 87 87 100.0 87 87 100.0 
Vermont 2 2 2 100.0 2 2 100.0 0 0 N/A 
Virginia 747 660 700 94.3 603 603 100.0 85 85 100.0 
Washington 629 315 341 92.4 245 245 100.0 189 189 100.0 
West Virginia 154 94 154 61.0 94 94 100.0 49 49 100.0 
Wisconsin 265 198 265 74.7 186 194 95.9 73 73 100.0 
Wyoming 8 8 8 100.0 8 8 100.0 8 8 100.0 
Puerto Rico 483 351 461 76.1 336 336 100.0 217 223 97.3 
U.S. Virgin Islands 4 3 4 75.0 3 3 100.0 0 0 N/A 
TOTAL 28,442 22,915 27,401 83.6 21,606 22,351 96.7 8,531 10,106 84.4 
aReported denominator excludes missing data.  
bReported percentage excludes missing data. 
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Table 5. Demographic and Risk Behavior Characteristics of Partners Elicited by and Tested Through Partner Services (PS), 59 Health Departments, 2017 
 
Demographic and Risk 
Characteristics 
Named Partners Initiated for PS Named Partners Who Were Notifiable  Notified Partners Notified Partners Tested for HIV 
N Column % N 
Reporteda 
Denominator 
Reportedb 
% N 
Reporteda 
Denominator 
Reportedb 
% N 
Reporteda 
Denominator 
Reportedb 
% 
AGE            
<13 35 0.1 31 34 91.2 23 31 74.2 13 14 92.9 
13-19 586 2.1 525 570 92.1 480 513 93.6 254 285 89.1 
20-29 9,368 32.9 7,975 9,129 87.4 7,573 7,855 96.4 3,264 3,777 86.4 
30-39 7,153 25.1 5,796 6,964 83.2 5,558 5,715 97.3 2,170 2,524 86.0 
40-49 3,728 13.1 3,038 3,632 83.6 2,942 3,000 98.1 1,126 1,341 84.0 
50+ 3,979 14.0 3,299 3,906 84.5 3,138 3,188 98.4 1,386 1,593 87.0 
Missing/Invalid 3,593 12.6 2,251 3,166 71.1 1,892 2,049 92.3 318 572 55.6 
GENDER            
Male 23,377 82.2 18,725 22,575 82.9 17,714 18,261 97.0 6,556 7,874 83.3 
Female 4,488 15.8 3,803 4,341 87.6 3,568 3,726 95.8 1,813 2,022 89.7 
Transgender 148 0.5 98 127 77.2 94 96 97.9 46 53 86.8 
Other 4 0.0 2 3 66.7 2 2 100.0 1 1 100.0 
Declined/Not Asked 366 1.3 231 298 77.5 212 212 100.0 111 149 74.5 
Missing/Invalid 59 0.2 56 57 98.2 16 54 29.6 4 7 57.1 
RACE/ETHNICITY            
White 8,509 29.9 6,914 8,141 84.9 6,367 6,731 94.6 2,761 3,225 85.6 
Black or African 
i  
11,437 40.2 9,255 11,083 83.5 8,855 9,039 98.0 3,539 4,211 84.0 
Hispanic or Latino 5,508 19.4 4,643 5,401 86.0 4,479 4,589 97.6 1,590 1,808 87.9 
Asian 310 1.1 249 302 82.5 234 242 96.7 99 124 79.8 
American Indian or 
Alaska Native 185 0.7 140 176 79.5 133 138 96.4 60 62 96.8 
Native Hawaiian or 
Pacific Islander 52 0.2 39 51 76.5 37 38 97.4 16 16 100.0 
Multi-race 249 0.9 178 231 77.1 159 173 91.9 59 69 85.5 
Declined 26 0.1 24 26 92.3 24 24 100.0 7 19 36.8 
Don't Know 1,704 6.0 1,186 1,652 71.8 1,115 1,126 99.0 275 433 63.5 
Missing/Invalid 462 1.6 287 338 84.9 203 251 80.9 125 139 89.9 
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Demographic and Risk 
Characteristics 
Named Partners Initiated for PS Named Partners Who Were Notifiable Notified Partners Notified Partners Tested for HIV 
N Column % N 
Reporteda 
Denominator 
Reportedb 
% N 
Reporteda 
Denominator 
Reportedb 
% N 
Reporteda 
Denominator 
Reportedb 
% 
REGION            
Northeast 3,454 12.1 1,998 3,310 60.4 1,802 1,973 91.3 807 1,065 75.8 
Midwest 3,053 10.7 2,445 3,038 80.5 1,697 2,191 77.5 917 1,133 80.9 
South 16,826 59.2 15,131 16,376 92.4 14,941 14,981 99.7 4,967 5,757 86.3 
West 4,622 16.3 2,987 4,212 70.9 2,827 2,867 98.6 1,623 1,928 84.2 
U.S. Dependent Areas 487 1.7 354 465 76.1 339 339 100.0 217 223 97.3 
SUBPOPULATION            
MSM/PWID 170 0.6 123 164 75.0 122 122 100.0 68 72 94.4 
MSM 4,103 14.4 3,225 4,007 80.5 3,142 3,177 98.9 1,688 1,877 89.9 
Transgender/PWID 1 0.0 1 1 100.0 1 1 100.0 1 1 100.0 
Transgender 147 0.5 97 126 77.0 93 95 97.9 45 52 86.5 
PWID 171 0.6 121 155 78.1 116 121 95.9 76 84 90.5 
Heterosexual Men 717 2.5 617 711 86.8 604 609 99.2 413 451 91.6 
Heterosexual Women 880 3.1 752 864 87.0 731 741 98.7 529 582 90.9 
No Risk 981 3.4 766 980 78.2 716 731 97.9 391 616 63.5 
Missing/Invalid 21,272 74.8 17,213 20,393 84.4 16,081 16,754 96.0 5,320 6,371 83.5 
TOTAL 28,442 100.0 22,915 27,401 83.6 21,606 22,351 96.7 8,531 10,106 84.4 
 
a
Reported denominator excludes missing data. 
 bReported percentage excludes missing data. 
  cMSM- Men who have sex with men 
  dPWID- People who inject drugs
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Table 6. Newly Identified HIV-positive Partners Linked to HIV Medical Care, 59 Health Departments, 2017 
Jurisdictions 
 
Notified Partners 
Tested 
 
Partners Newly Identified as HIV-Positive Newly Identified Partners Attended First HIV Medical Care Appointment 
N Reported Denominator Reported % N 
Reported 
Denominator Reported % 
Alabama 213 36 125 28.8 29 29 100.0 
Alaska 62 2 61 3.3 2 2 100.0 
Arizona 424 29 411 7.1 11 12 91.7 
Arkansas 155 6 150 4.0 3 3 100.0 
California (excludes LA SF) 55 3 35 8.6 2 2 100.0 
Los Angeles 64 12 62 19.4 3 4 75.0 
San Francisco 106 7 102 6.9 4 4 100.0 
Colorado 232 42 231 18.2 40 40 100.0 
Connecticut 31 2 29 6.9 0 0 N/A 
Delaware 2 0 2 0.0 N/A N/A N/A 
District of Columbia 6 4 6 66.7 0 1 0.0 
Florida 1,665 57 1,614 3.5 38 38 100.0 
Georgia (excludes Atlanta) 66 13 66 19.7 3 3 100.0 
Atlanta 26 6 26 23.1 0 0 N/A 
Hawaii 11 0 11 0.0 N/A N/A N/A 
Idaho N/A N/A N/A N/A N/A N/A N/A 
Illinois (excludes Chicago) 11 1 11 9.1 0 1 0.0 
Indiana 80 42 58 72.4 29 42 69.0 
Iowa 89 9 88 10.2 5 5 100.0 
Kansas 31 31 31 100.0 26 26 100.0 
Kentucky 22 0 0 N/A N/A N/A N/A 
Louisiana 239 27 235 11.5 14 14 100.0 
Maine N/A N/A N/A N/A N/A N/A N/A 
Maryland (excludes Baltimore) 228 7 221 3.2 2 2 100.0 
Baltimore 85 2 81 2.5 1 1 100.0 
Massachusetts 8 0 4 0.0 N/A N/A N/A 
Michigan 78 8 77 10.4 3 3 100.0 
Mississippi 388 17 375 4.5 9 11 81.8 
Missouri 120 9 117 7.7 6 6 100.0 
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aReported denominator excludes missing data. 
 bReported percentage excludes missing data. 
Jurisdictions 
 
Notified Partners 
Tested 
 
Partners Newly Identified as HIV-Positive Newly Identified Partners Attended First HIV Medical Care Appointment 
N Reported Denominator Reported % N 
Reported 
Denominator Reported % 
Montana 1 1 1 100.0 0 0 N/A 
Nebraska 17 3 17 17.6 0 0 N/A 
Nevada 256 21 253 8.3 16 16 100.0 
New Hampshire 1 0 1 0.0 N/A N/A N/A 
New Jersey 45 8 44 18.2 7 7 100.0 
New Mexico 59 12 57 21.1 8 8 100.0 
New York (excludes New York City) 217 25 216 11.6 8 8 100.0 
New York City 168 34 168 20.2 32 33 97.0 
North Carolina 776 435 774 56.2 47 47 100.0 
North Dakota 21 1 21 4.8 0 0 N/A 
Ohio 387 67 386 17.4 59 60 98.3 
Oklahoma 0 N/A N/A N/A N/A N/A N/A 
Oregon 69 15 69 21.7 0 0 N/A 
Pennsylvania (excludes Philadelphia) 39 19 37 51.4 16 16 100.0 
Philadelphia 251 14 251 5.6 10 10 100.0 
Rhode Island 47 5 47 10.6 4 4 100.0 
South Carolina 269 171 268 63.8 73 73 100.0 
South Dakota 10 5 10 50.0 3 3 100.0 
Tennessee 311 69 298 23.2 0 0 N/A 
Texas (includes Houston) 382 2 5 40.0 0 0 N/A 
Utah 87 87 87 100.0 0 0 N/A 
Vermont 0 N/A N/A N/A N/A N/A N/A 
Virginia 85 0 21 0.0 N/A N/A N/A 
Washington 189 26 179 14.5 1 1 100.0 
West Virginia 49 0 0 N/A N/A N/A N/A 
Wisconsin 73 11 73 15.1 8 9 88.9 
Wyoming 8 0 3 0.0 N/A N/A N/A 
Puerto Rico 217 53 213 24.9 41 41 100.0 
U.S. Virgin Islands 0 N/A N/A N/A N/A N/A N/A 
TOTAL 8,531 1,456 7,728 18.8 563 585 96.2 
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Table 7. Demographic and Risk Behavior Characteristics of Newly Identified HIV-positive Partners Linked to HIV Medical Care, 59 Health Departments, 2017 
Demographic and 
Risk Characteristics 
 
Notified Partners Tested Partners Newly Identified as HIV-positive Newly Identified Partners Attended First HIV Medical Care Appointment 
N Column % N Reported
a 
Denominator 
Reportedb 
% N 
Reporteda 
Denominator 
Reportedb 
% 
AGE         
<13 13 0.2 2 13 15.4 0 0 N/A 
13-19 254 3.0 33 242 13.6 17 18 94.4 
20-29 3,264 38.3 513 2,899 17.7 222 233 95.3 
30-39 2,170 25.4 336 1,963 17.1 151 158 95.6 
40-49 1,126 13.2 144 1,013 14.2 73 74 98.6 
50+ 1,386 16.2 354 1,318 26.9 92 93 98.9 
Missing/Invalid 318 3.7 74 280 26.4 8 9 88.9 
GENDER         
Male 6,556 76.8 1,159 5,845 19.8 445 465 95.7 
Female 1,813 21.3 239 1,725 13.9 115 117 98.3 
Transgender 46 0.5 8 45 17.8 3 3 100.0 
Other 1 0.0 0 1 0.0 N/A N/A N/A 
Declined/Not Asked 111 1.3 50 109 45.9 0 0 N/A 
Missing/Invalid 4 0.0 0 3 0.0 N/A N/A N/A 
RACE/ETHNICITY         
White 2,761 32.4 407 2,510 16.2 176 186 94.6 
Black or African American 3,539 41.5 697 3,222 21.6 226 236 95.8 
Hispanic or Latino 1,590 18.6 244 1,399 17.4 131 131 100.0 
Asian 99 1.2 10 92 10.9 6 6 100.0 
American Indian or 
Alaska Native 60 0.7 8 57 14.0 4 5 80.0 
Native Hawaiian or Pacific Islander 16 0.2 1 13 7.7 1 1 100.0 
Multi-race 59 0.7 16 49 32.7 5 5 100.0 
Declined 7 0.1 0 7 0.0 N/A N/A N/A 
Don't Know 275 3.2 16 260 6.2 9 10 90.0 
Missing/Invalid 125 1.5 57 119 47.9 5 5 100.0 
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Demographic and 
Risk Characteristics 
 
Notified Partners Tested Partners Newly Identified as HIV-positive Newly Identified Partners Attended First HIV Medical Care Appointment 
N Column % N Reported
a 
Denominator 
Reportedb 
% N 
Reporteda 
Denominator 
Reportedb 
% 
REGION         
Northeast 807 9.5 107 797 13.4 77 78 98.7 
Midwest 917 10.7 187 889 21.0 139 155 89.7 
South 4,967 58.2 852 4,267 20.0 219 222 98.6 
West 1,623 19.0 257 1,562 16.5 87 89 97.8 
U.S. Dependent Areas 217 2.5 53 213 24.9 41 41 100.0 
TARGET POPULATION         
MSM/PWID 68 0.8 21 63 33.3 7 8 87.5 
MSM 1,688 19.8 583 1,566 37.2 254 261 97.3 
Transgender/PWID 1 0.0 0 1 0.0 N/A N/A N/A 
Transgender 45 0.5 8 44 18.2 3 3 100.0 
PWID 76 0.9 34 69 49.3 15 19 78.9 
Heterosexual Men 413 4.8 118 387 30.5 64 64 100.0 
Heterosexual Women 529 6.2 133 508 26.2 73 73 100.0 
No Risk 391 4.6 37 377 9.8 16 17 94.1 
Missing/Invalid 5,320 62.4 522 4,713 11.1 131 140 93.6 
TOTAL 8,531 100.0 1,456 7,728 18.8 563 585 96.2 
a
Reported denominator excludes missing data. 
 bReported percentage excludes missing data. 
  cMSM- Men who have sex with men 
  dPWID- People who inject drugs 
